Wolf-Dieter Ludwig

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Living Beings

Infant

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Braess Jan; Spiekermann Karsten; Staib Peter; Grüneisen Andreas; Wörmann Bernhard; Ludwig Wolf-Dieter; Serve Hubert; Reichle Albrecht; Peceny Rudolf; Oruzio Daniel; Schmid Christoph; Schiel Xaver; Hentrich Marcus; Sauerland Christina; Unterhalt Michael; Fiegl Michael; Kern Wolfgang; Buske Christian; Bohlander Stefan; Heinecke Achim; Baurmann Herrad; Beelen Dietrich W; Berdel Wolfgang E; Büchner Thomas; Hiddemann Wolfgang
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.
Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig W-D; Karawajew L;
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
Buske C; Hoster E; Dreyling M; Eimermacher H; Wandt H; Metzner B; Fuchs R; Bittenbring J; Woermann B; Hohloch K; Hess G; Ludwig W-D; Schimke J; Schmitz S; Kneba M; Reiser M; Graeven U; Klapper W; Unterhalt M; Hiddemann W;
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Wolf-Dieter Ludwig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Braess Jan; Spiekermann Karsten; Staib Peter; Grüneisen Andreas; Wörmann Bernhard; Ludwig Wolf-Dieter; Serve Hubert; Reichle Albrecht; Peceny Rudolf; Oruzio Daniel; Schmid Christoph; Schiel Xaver; Hentrich Marcus; Sauerland Christina; Unterhalt Michael; Fiegl Michael; Kern Wolfgang; Buske Christian; Bohlander Stefan; Heinecke Achim; Baurmann Herrad; Beelen Dietrich W; Berdel Wolfgang E; Büchner Thomas; Hiddemann Wolfgang
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.
Blood 2009;113(17):3903-10.
2009: Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig W-D; Karawajew L;
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):528-34.
2009: Buske C; Hoster E; Dreyling M; Eimermacher H; Wandt H; Metzner B; Fuchs R; Bittenbring J; Woermann B; Hohloch K; Hess G; Ludwig W-D; Schimke J; Schmitz S; Kneba M; Reiser M; Graeven U; Klapper W; Unterhalt M; Hiddemann W;
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(1):153-61.
2009: Dören Martina; Gerhardus Ansgar; Gerlach Ferdinand M; Hornberg Claudia; Kochen Michael M; Kolip Petra; Ludwig Wolf-Dieter; Mühlhauser Ingrid; Razum Oliver; Rosenbrock Rolf; Schach Corinna; Schmacke Norbert; Windeler Jürgen
[Scientists call for a reevaluation of HPV vaccination and an end to the misleading information]
Pharmazie in unserer Zeit 2009;38(2):186-7.
2008: Steinemann Doris; Cario Gunnar; Stanulla Martin; Karawajew Leonid; Tauscher Marcel; Weigmann Anja; Göhring Gudrun; Ludwig Wolf-Dieter; Harbott Jochen; Radlwimmer Bernhard; Bartram Claus; Lichter Peter; Schrappe Martin; Schlegelberger Brigitte
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Genes, chromosomes & cancer 2008;47(6):471-80.
2008: Dudeck Oliver; Zeile Martin; Pink Daniel; Pech Maciej; Tunn Per-Ulf; Reichardt Peter; Ludwig Wolf-Dieter; Hamm Bernd
Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.
Journal of magnetic resonance imaging : JMRI 2008;27(5):1109-13.
2008: Möricke Anja; Reiter Alfred; Zimmermann Martin; Gadner Helmut; Stanulla Martin; Dördelmann Michael; Löning Lutz; Beier Rita; Ludwig Wolf-Dieter; Ratei Richard; Harbott Jochen; Boos Joachim; Mann Georg; Niggli Felix; Feldges Andreas; Henze Günter; Welte Karl; Beck Jörn-Dirk; Klingebiel Thomas; Niemeyer Charlotte; Zintl Felix; Bode Udo; Urban Christian; Wehinger Helmut; Niethammer Dietrich; Riehm Hansjörg; Schrappe Martin;
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: Haas Katja; Kundi Michael; Sperr Wolfgang R; Esterbauer Harald; Ludwig Wolf-Dieter; Ratei Richard; Koller Elisabeth; Gruener Helga; Sauerland Cristina; Fonatsch Christa; Valent Peter; Wieser Rotraud
Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
Genes, chromosomes & cancer 2008;47(4):288-98.
2008: Ratei Richard; Karawajew Leonid; Schabath Richard; Ehrfeldt Angelika; Grunert Fritz; Ludwig Wolf-Dieter
Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias.
International journal of hematology 2008;87(2):137-43.
2008: Burkhardt Birgit; Moericke Anja; Klapper Wolfram; Greene Franziska; Salzburg Janina; Damm-Welk Christine; Zimmermann Martin; Strauch Konstantin; Ludwig Wolf-Dieter; Schrappe Martin; Reiter Alfred
Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
Leukemia & lymphoma 2008;49(3):451-61.
2008: Hoster Eva; Dreyling Martin; Klapper Wolfram; Gisselbrecht Christian; van Hoof Achiel; Kluin-Nelemans Hanneke C; Pfreundschuh Michael; Reiser Marcel; Metzner Bernd; Einsele Hermann; Peter Norma; Jung Wolfram; Wörmann Bernhard; Ludwig Wolf-Dieter; Dührsen Ulrich; Eimermacher Hartmut; Wandt Hannes; Hasford Joerg; Hiddemann Wolfgang; Unterhalt Michael;
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Blood 2008;111(2):558-65.
2008: Müller-Oerlinghausen Bruno; Ludwig Wolf-Dieter
[Improving drug safety in Germany: an alliance between the government and the medical profession]
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2008;102(9):582-6; discussion 593, 606-8.
2007: Dudeck Oliver; Zeile Martin; Poellinger Alexander; Kluhs Lothar; Ludwig Wolf-Dieter; Hamm Bernd
Epidural venous enlargements presenting with intractable lower back pain and sciatica in a patient with absence of the infrarenal inferior vena cava and bilateral deep venous thrombosis.
Spine 2007;32(23):E688-91.
2007: Mann Georg; Attarbaschi Andishe; Burkhardt Birgit; Niggli Felix; Klapper Wolfram; Ludwig Wolf-Dieter; Schrappe Martin; Zimmermann Martin; Gadner Helmut; Reiter Alfred;
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
British journal of haematology 2007;139(3):443-9.
2007: Cario Gunnar; Izraeli Shai; Teichert Anja; Rhein Peter; Skokowa Julia; Möricke Anja; Zimmermann Martin; Schrauder Andre; Karawajew Leonid; Ludwig Wolf-Dieter; Welte Karl; Schünemann Holger J; Schlegelberger Brigitte; Schrappe Martin; Stanulla Martin
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4813-20.
2007: Salzburg Janina; Burkhardt Birgit; Zimmermann Martin; Wachowski Olga; Woessmann Wilhelm; Oschlies Ilske; Klapper Wolfram; Wacker Hans-Heinrich; Ludwig Wolf-Dieter; Niggli Felix; Mann Georg; Gadner Helmut; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3915-22.
2007: Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig W-D; Gratama J W; Orfao A;
Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1204-11.
2007: Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig W-D; Karawajew L
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(5):897-905.
2006: Schrauder André; Reiter Alfred; Gadner Helmut; Niethammer Dietrich; Klingebiel Thomas; Kremens Bernhard; Peters Christina; Ebell Wolfram; Zimmermann Martin; Niggli Felix; Ludwig Wolf-Dieter; Riehm Hansjörg; Welte Karl; Schrappe Martin
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5742-9.
2006: Wagner Mandy; Schmelz Karin; Wuchter Christian; Ludwig Wolf-Dieter; Dörken Bernd; Tamm Ingo
In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
International journal of cancer. Journal international du cancer 2006;119(6):1291-7.
2006: Kirschner-Schwabe Renate; Lottaz Claudio; Tödling Jörn; Rhein Peter; Karawajew Leonid; Eckert Cornelia; von Stackelberg Arend; Ungethüm Ute; Kostka Dennis; Kulozik Andreas E; Ludwig Wolf-Dieter; Henze Günter; Spang Rainer; Hagemeier Christian; Seeger Karl
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4553-61.
2006: Burkhardt B; Bruch J; Zimmermann M; Strauch K; Parwaresch R; Ludwig W-D; Harder L; Schlegelberger B; Mueller F; Harbott J; Reiter A
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1422-9.
2006: Breit Stephen; Stanulla Martin; Flohr Thomas; Schrappe Martin; Ludwig Wolf-Dieter; Tolle Gabriele; Happich Margit; Muckenthaler Martina U; Kulozik Andreas E
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
Blood 2006;108(4):1151-7.
2006: Büchner Thomas; Berdel Wolfgang E; Schoch Claudia; Haferlach Torsten; Serve Hubert L; Kienast Joachim; Schnittger Susanne; Kern Wolfgang; Tchinda Joelle; Reichle Albrecht; Lengfelder Eva; Staib Peter; Ludwig Wolf-Dieter; Aul Carlo; Eimermacher Hartmut; Balleisen Leopold; Sauerland Maria-Cristina; Heinecke Achim; Wörmann Bernhard; Hiddemann Wolfgang
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2480-9.
2006: Burkhardt Birgit; Woessmann Wilhelm; Zimmermann Martin; Kontny Udo; Vormoor Josef; Doerffel Wolfgang; Mann Georg; Henze Guenter; Niggli Felix; Ludwig Wolf-Dieter; Janssen Dirk; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):491-9.
2006: Ratei Richard; Karawajew Leonid; Lacombe Francis; Jagoda Krystyna; Del Poeta Giovanni; Kraan Jaco; De Santiago Maria; Kappelmayer János; Björklund Elisabeth; Ludwig W-D; Gratama Jan; Orfao Alberto;
Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
Cytometry. Part B, Clinical cytometry 2006;70(1):1-9.
2005: Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig W-D; Riehm H; Schrappe M
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Klinische Pädiatrie 2005;217(6):310-20.
2005: Einsiedel Hagen Graf; von Stackelberg Arend; Hartmann Reinhard; Fengler Rüdiger; Schrappe Martin; Janka-Schaub Gritta; Mann Georg; Hählen Karel; Göbel Ulrich; Klingebiel Thomas; Ludwig Wolf-Dieter; Henze Günter
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7942-50.
2005: Karawajew Leonid; Rhein Peter; Czerwony Grit; Ludwig Wolf-Dieter
Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species.
Blood 2005;105(12):4767-75.
2005: Scholz Christian; Nimmrich Inko; Burger Matthias; Becker Evelyne; Dörken Bernd; Ludwig Wolf-Dieter; Maier Sabine
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Annals of hematology 2005;84(4):236-44.
2005: Stanulla Martin; Schaeffeler Elke; Flohr Thomas; Cario Gunnar; Schrauder André; Zimmermann Martin; Welte Karl; Ludwig Wolf-Dieter; Bartram Claus R; Zanger Ulrich M; Eichelbaum Michel; Schrappe Martin; Schwab Matthias
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
JAMA : the journal of the American Medical Association 2005;293(12):1485-9.
2005: Woessmann Wilhelm; Seidemann Kathrin; Mann Georg; Zimmermann Martin; Burkhardt Birgit; Oschlies Ilske; Ludwig Wolf-Dieter; Klingebiel Thomas; Graf Norbert; Gruhn Bernd; Juergens Heribert; Niggli Felix; Parwaresch Reza; Gadner Helmut; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred;
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Blood 2005;105(3):948-58.
2005: Buechner Thomas; Berdel Wolfgang E; Schoch Claudia; Haferlach Torsten; Serve Hubert L; Schnittger Susanne; Kern Wolfgang; Tchinda Joelle; Reichle Albrecht; Staib Peter; Ludwig Wolf-Dieter; Aul Carlo; Sauerland Maria-Cristina; Heinecke Achim; Woermann Bernhard; Hiddemann Wolfgang;
Treatment of AML in biological subgroups.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():281-85.
2004: Meissner B; Stanulla M; Ludwig W-D; Harbott J; Möricke A; Welte K; Schrappe M
The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(11):1920-3.
2004: Tamm Ingo; Richter Stephan; Oltersdorf Doreen; Creutzig Ursula; Harbott Jochen; Scholz Frank; Karawajew Leonid; Ludwig Wolf-Dieter; Wuchter Christian
High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3737-44.
2004: Müller-Tidow C; Metzelder S K; Buerger H; Packeisen J; Ganser A; Heil G; Kügler K; Adigüzel G; Schwäble J; Steffen B; Ludwig W-D; Heinecke A; Büchner T; Berdel W E; Serve H
Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):720-6.
2004: Dworzak M N; Fröschl G; Printz D; Zen L De; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig W-D; Gadner H
CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):703-8.
2004: Wuchter Christian; Richter Stephan; Oltersdorf Doreen; Karawajew Leonid; Ludwig Wolf-Dieter; Tamm Ingo
Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemia.
Haematologica 2004;89(3):363-4.
2004: Cai Zhen; Bao Han-ying; Ludwig Wolf-Dieter; Wuchter Christian
[Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1]
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2004;25(1):26-30.
2004: Gaffke Gunnar; Stroszczynski Christian; Gnauck Manuela; Jost Dominik; Chmelik Petra; Ludwig Wolf-Dieter; Gretschel Stefan; Felix Roland
[Differential diagnosis of intra- and perilienal tumors by use of a RES-specific MRI contrast agent]
Röntgenpraxis; Zeitschrift für radiologische Technik 2004;55(5):192-9.
2004: Tamm Ingo; Richter Stephan; Scholz Frank; Schmelz Karin; Oltersdorf Doreen; Karawajew Leonid; Schoch Claudia; Haferlach Torsten; Ludwig Wolf-Dieter; Wuchter Christian
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(6):489-95.
2004: Ludwig Wolf-Dieter
Minimal residual disease detection by flow cytometry.
Laboratory hematology : official publication of the International Society for Laboratory Hematology 2004;10(3):169.
2004: Büchner Th; Hiddemann W; Berdel W E; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig W D; Maschmeyer G; Staib P; Balleisen L; Grüneisen A; Aul C; Lengfelder E; Hehlmann R; Kern W; Serve H L; Mesters R M; Eimermacher H; Frickhofen N; Kienast J; Giagounidis A; Sauerland M C; Heinecke A;
Subgroup specific therapy effects in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S100-1.
2003: Büchner Thomas; Hiddemann Wolfgang; Berdel Wolfgang E; Wörmann Bernhard; Schoch Claudia; Fonatsch Christa; Löffler Helmut; Haferlach Torsten; Ludwig Wolf-Dieter; Maschmeyer Georg; Staib Peter; Aul Carlo; Gruneisen Andreas; Lengfelder Eva; Frickhofen Norbert; Kern Wolfgang; Serve Hubert L; Mesters Rolf M; Sauerland Maria Cristina; Heinecke Achim;
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4496-504.
2003: Kern Wolfgang; Kohlmann Alexander; Wuchter Christian; Schnittger Susanne; Schoch Claudia; Mergenthaler Susanne; Ratei Richard; Ludwig Wolf-Dieter; Hiddemann Wolfgang; Haferlach Torsten
Correlation of protein expression and gene expression in acute leukemia.
Cytometry. Part B, Clinical cytometry 2003;55(1):29-36.
2003: Benter T; Klühs L; Teichgräber U K; Riechert F; Ludwig W D; Dörken B
Need for safety goggles for endoscopy.
Endoscopy 2003;35(9):803.
2003: Kern Wolfgang; Danhauser-Riedl Susanne; Ratei Richard; Schnittger Susanne; Schoch Claudia; Kolb Hans-Jochem; Ludwig Wolf-Dieter; Hiddemann Wolfgang; Haferlach Torsten
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Haematologica 2003;88(6):646-53.
2003: Klühs L; Teichgräber U K M; Schneider U; Ludwig W-D; Dörken B; Benter T
[Accuracy of the sonographic determination of the splenic weight in comparison with the weight at autopsy]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(4):532-5.
2003: Haferlach Torsten; Schoch Claudia; Löffler Helmut; Gassmann Winfried; Kern Wolfgang; Schnittger Susanne; Fonatsch Christa; Ludwig Wolf-Dieter; Wuchter Christian; Schlegelberger Brigitte; Staib Peter; Reichle Albrecht; Kubica Uschi; Eimermacher Hartmut; Balleisen Leopold; Grüneisen Andreas; Haase Detlef; Aul Carlo; Karow Jochen; Lengfelder Eva; Wörmann Bernhard; Heinecke Achim; Sauerland Maria Cristina; Büchner Thomas; Hiddemann Wolfgang
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):256-65.
2002: Hoelzer D; Arnold R; Bartram C R; Böhme A; Freund M; Ganser A; Kneba M; Lipp T; Ludwig W D; Maschmeyer G; Rieder H; Thiel E; Messerer D; Weiss A; Gökbuget N
[Acute lymphatic leukemia in the adult. Diagnosis, risk groups and therapy]
Der Internist 2002;43(10):1212-6, 1219-22, 1224-7.
2002: Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig W-D; Janka-Schaub G; Schrappe M; Harbott J
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1685-90.
2002: Wuchter Christian; Ruppert Velia; Schrappe Martin; Dörken Bernd; Ludwig Wolf-Dieter; Karawajew Leonid
In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
Blood 2002;99(11):4109-15.
2002: Papadopoulos Sarantos; Benter Thomas; Anastassiou Gerasimos; Pape Michael; Gerhard Schaller; Bornfeld Norbert; Ludwig Wolf-Dieter; Dörken Bernd
Assessment of genomic instability in breast cancer and uveal melanoma by random amplified polymorphic DNA analysis.
International journal of cancer. Journal international du cancer 2002;99(2):193-200.
2002: Büchner Thomas; Hiddemann Wolfgang; Berdel Wolfgang; Wörmann Bernhard; Schoch Claudia; Löffler Helmut; Haferlach Torsten; Schumacher Andrea; Staib Peter; Balleisen Leopold; Grüneisen Andreas; Rasche Herbert; Aul Carlo; Heyll Axel; Lengfelder Eva; Ludwig Wolf-Dieter; Maschmeyer Georg; Eimermacher Hartmut; Karow Jochen; Frickhofen Norbert; Hirschmann Wolf-Dietrich; Sauerland Maria-Cristina;
Acute myeloid leukemia: treatment over 60.
Reviews in clinical and experimental hematology 2002;6(1):46-59; discussion 86-7.
2002: Benter Thomas; Kretzschmar Albrecht; Reich Gernot; Papadopoulos Sarantos; Klühs Lothar; Ludwig Wolf-Dieter; Dörken Bernd
[Therapy of Zenker's diverticulum]
Medizinische Klinik (Munich, Germany : 1983) 2002;97(1):44-5.
2002: Gaffke Gunnar; Stroszczynski Christian; Schlecht Inge; Jost Dominik; Ludwig Wolf-Dieter; Schlag Peter M; Felix Roland
[Diagnosis of tumors of the small intestine with the aid of CT contrast enema. Sellink CT technique evaluated in 63 patients]
Röntgenpraxis; Zeitschrift für radiologische Technik 2002;54(6):214-9.
2002: Gaffke Gunnar; Stroszczynski Christian; Ludwig Wolf-Dieter; Puls Ralf; Schlecht Inge; Jost Dominik; Hosten Norbert; Felix Roland
[BALTOMA--long-term follow-up]
Röntgenpraxis; Zeitschrift für radiologische Technik 2002;54(5):186-91.
2001: Büchner T; Hiddemann W; Berdel W; Wörmann B; Löffler H; Schoch C; Haferlach T; Ludwig W D; Maschmeyer G; Staib P; Andreesen R; Balleisen L; Haase D; Eimermacher H; Aul C; Rasche H; Uhlig J; Grüneisen A; Reis H E; Hartlapp J; Hirschmann W D; Weh H J; Pielken H J; Gassmann W; Sauerland M C; Heinecke A
Remission induction therapy: the more intensive the better?
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S41-4.
2001: Fuchs U; Rehkamp G; Haas O A; Slany R; Konig M; Bojesen S; Bohle R M; Damm-Welk C; Ludwig W D; Harbott J; Borkhardt A
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(15):8756-61.
2001: Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig W D; Karawajew L
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(6):921-8.
2001: Cai Z; Lin M; Ludwig W D; Karawajew L
[Involvement of mitochondrial membrane potential in the homoharringtonine induced apoptosis of leukemic T-cells]
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2001;22(5):238-40.
2001: Cai Z; Lin M; Wuchter C; Ruppert V; Dörken B; Ludwig W D; Karawajew L
Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(4):567-74.
2001: Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig W D
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Haematologica 2001;86(2):154-61.
2001: Grenzebach J; Schrappe M; Ludwig W D; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Annals of hematology 2001;80 Suppl 3():B73-6.
2000: Ratei R; Matylis A; Krahl D; Arnold R; Stein H; Dörken B; Ludwig W D
Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8.
Leukemia & lymphoma 2000;40(1-2):133-40.
2000: Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig W D; Henze G; Gadner H; Odenwald E; Riehm H
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2205-22.
2000: Gökbuget N; Hoelzer D; Arnold R; Böhme A; Bartram C R; Freund M; Ganser A; Kneba M; Langer W; Lipp T; Ludwig W D; Maschmeyer G; Rieder H; Thiel E; Weiss A; Messerer D
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).
Hematology/oncology clinics of North America 2000;14(6):1307-25, ix.
2000: Büchner T; Hiddemann W; Wörmann B; Löffler H; Ludwig W D; Schoch C; Haferlach T; Maschmeyer G; Staib P; Aul C; Heyll G A; Grüneisen A; Rasche H; Eimermacher J H; Balleisen L; Pielken H J; Reis H E; Griesinger F; Reichle A; Sauerland M C; Heinecke A;
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?
International journal of hematology 2000;72(3):285-9.
2000: Lengfelder E; Reichert A; Schoch C; Haase D; Haferlach T; Löffler H; Staib P; Heyll A; Seifarth W; Saussele S; Fonatsch C; Gassmann W; Ludwig W D; Hochhaus A; Beelen D; Aul C; Sauerland M C; Heinecke A; Hehlmann R; Wörmann B; Hiddemann W; Büchner T
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1362-70.
2000: Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig W D
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(1):154-60.
2000: Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig W D
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1232-8.
2000: Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig W D
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Haematologica 2000;85(7):711-21.
2000: Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig W D
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Blood 2000;96(1):297-306.
2000: Neth O; Seidemann K; Jansen P; Mann G; Tiemann M; Ludwig W D; Riehm H; Reiter A
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
Medical and pediatric oncology 2000;35(1):20-7.
2000: Schrappe M; Reiter A; Ludwig W D; Harbott J; Zimmermann M; Hiddemann W; Niemeyer C; Henze G; Feldges A; Zintl F; Kornhuber B; Ritter J; Welte K; Gadner H; Riehm H
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
2000: Kordes U; Krappmann D; Heissmeyer V; Ludwig W D; Scheidereit C
Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(3):399-402.
2000: Stanulla M; Kasper B; Schrappe M; Viehmann S; Harbott J; Ludwig W D; Welte K
Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):337-8.
2000: Bohlander S K; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig W D; Hiddemann W; Dreyling M H
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(1):93-9.
2000: Reiter A; Schrappe M; Ludwig W D; Tiemann M; Parwaresch R; Zimmermann M; Schirg E; Henze G; Schellong G; Gadner H; Riehm H
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood 2000;95(2):416-21.
1999: Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig W D
Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):1943-53.
1999: Reiter A; Schrappe M; Tiemann M; Ludwig W D; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss H J; Zintl F; Henze G; Riehm H
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: Dördelmann M; Reiter A; Borkhardt A; Ludwig W D; Götz N; Viehmann S; Gadner H; Riehm H; Schrappe M
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Blood 1999;94(4):1209-17.
1999: Büchner T; Hiddemann W; Wörmann B; Löffler H; Gassmann W; Haferlach T; Fonatsch C; Haase D; Schoch C; Hossfeld D; Lengfelder E; Aul C; Heyll A; Maschmeyer G; Ludwig W D; Sauerland M C; Heinecke A
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.
Blood 1999;93(12):4116-24.
1999: Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig W D; Thiel E
Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
Leukemia & lymphoma 1999;34(1-2):85-94.
1999: Schwartz S; Behre G; Heinemann V; Wandt H; Schilling E; Arning M; Trittin A; Kern W V; Boenisch O; Bosse D; Lenz K; Ludwig W D; Hiddemann W; Siegert W; Beyer J
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.
Blood 1999;93(11):3654-61.
1999: Gökbuget N; Arnold R; Büchner T; Freund M; Gassmann W; Heil G; Hiddemann W; Löffler H; Lipp T; Ludwig W D; Maschmeyer G; Thiel E; Messerer D; Hoelzer D
[Treatment of adult acute lymphoblastic leukemia]
Praxis 1999;88(10):407-20.
1998: Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig W D
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Annals of hematology 1998;77(3):107-14.
1998: Rieder H; Bonwetsch C; Janssen L A; Maurer J; Janssen J W; Schwartz S; Ludwig W D; Gassmann W; Bartram C R; Thiel E; Löffler H; Gökbuget N; Hoelzer D; Fonatsch C
High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(9):1473-81.
1998: Ludwig W D; Rieder H; Bartram C R; Heinze B; Schwartz S; Gassmann W; Löffler H; Hossfeld D; Heil G; Handt S; Heyll A; Diedrich H; Fischer K; Weiss A; Völkers B; Aydemir U; Fonatsch C; Gökbuget N; Thiel E; Hoelzer D
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.
Blood 1998;92(6):1898-909.
1998: Tomeczkowski J; Frick D; Schwinzer B; Wittner N; Ludwig W D; Reiter A; Welte K; Sykora K W
Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(8):1221-9.
1998: Kern W; Aul C; Maschmeyer G; Schönrock-Nabulsi R; Ludwig W D; Bartholomäus A; Bettelheim P; Wörmann B; Büchner T; Hiddemann W
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(7):1049-55.
1998: Schott G; Sperling C; Schrappe M; Ratei R; Martin M; Meyer U; Riehm H; Ludwig W D
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
British journal of haematology 1998;101(4):753-5.
1998: Ritterbach J; Hiddemann W; Beck J D; Schrappe M; Janka-Schaub G; Ludwig W D; Harbott J; Lampert F
Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(3):427-33.
1997: Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig W D; Eichstädt H; Felix R
[Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1997;167(5):458-66.
1997: Haferlach T; Winkemann M; Ramm-Petersen L; Meeder M; Schoch R; Weber-Matthiesen K; Schlegelberger B; Schoch C; Ludwig W D; Hiddemann W; Löffler H
New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
British journal of haematology 1997;99(2):452-9.
1997: Sperling C; Schwartz S; Büchner T; Thiel E; Ludwig W D
Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias.
Haematologica 1997;82(5):617-21.
1997: Karawajew L; Wuchter C; Ruppert V; Drexler H; Gruss H J; Dörken B; Ludwig W D
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(8):1245-52.
1997: Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi M G; Zimmermann M; Ludwig W D; Basso G; Masera G; Riehm H
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2786-91.
1997: Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi M G; Ludwig W D; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
Blood 1997;90(2):571-7.
1997: Gassmann W; Löffler H; Thiel E; Ludwig W D; Schwartz S; Haferlach T; Maurer J; Rieder H; Fonatsch C; Gökbuget N; Hoelzer D
Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German Multicentre ALL Study Group (GMALL).
British journal of haematology 1997;97(2):372-82.
1997: Büchner T; Hiddemann W; Wörmann B; Zühlsdorf M; Rottmann R; Innig G; Maschmeier G; Ludwig W D; Sauerland M C; Heinecke A
Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects.
Seminars in oncology 1997;24(1):124-31.
1997: Mielcarek M; Sperling C; Schrappe M; Meyer U; Riehm H; Ludwig W D
Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome.
British journal of haematology 1997;96(2):301-7.
1996: Rieder H; Ludwig W D; Gassmann W; Maurer J; Janssen J W; Gökbuget N; Schwartz S; Thiel E; Löffler H; Bartram C R; Hoelzer D; Fonatsch C
Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia.
British journal of haematology 1996;95(4):678-91.
1996: Creutzig U; Ritter J; Vormoor J; Ludwig W D; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(11):1677-86.
1996: Haferlach T; Bennett J M; Löffler H; Gassmann W; Andersen J W; Tuzuner N; Casslleth P A; Fonatsch C; Schoch C; Schlegelberger B; Becher R; Thiel E; Ludwig W D; Sauerland M C; Heinecke A; Büchner T
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.
Leukemia & lymphoma 1996;23(3-4):227-34.
1996: Hoelzer D; Gökbuget N; Arnold R; Büchner T; Freund M; Gassmann W; Heil G; Hiddemann W; Löffler H; Lipp T; Ludwig W D; Maschmeyer G; Thiel E; Messerer D
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy]
Der Internist 1996;37(10):994-1007.
1996: Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen J W; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram C R; Ludwig W D; Riehm H; Lampert F; Harbott J
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(6):957-63.
1996: Schumann R R; Nakarai T; Gruss H J; Brach M A; von Arnim U; Kirschning C; Karawajew L; Ludwig W D; Renauld J C; Ritz J; Herrmann F
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Blood 1996;87(6):2419-27.
1996: Schmidt C A; Przybylski G; Tietze A; Oettle H; Siegert W; Ludwig W D
Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements.
British journal of haematology 1996;92(4):929-36.
1996: Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig W D; Grote W; Löffler H; Schlegelberger B
Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
British journal of haematology 1996;92(3):673-80.
1996: Ratei R; Sperling C; Ludwig W D
[Morphological, immunological and cytogenetic diagnosis in acute leukemias]
Therapeutische Umschau. Revue thérapeutique 1996;53(2):88-96.
1996: Beyermann B; Agthe A G; Adams H P; Seeger K; Linderkamp C; Goetze G; Ludwig W D; Henze G
Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.
Blood 1996;87(4):1532-8.
1996: Hoelzer D; Ludwig W D; Thiel E; Gassmann W; Löffler H; Fonatsch C; Rieder H; Heil G; Heinze B; Arnold R; Hossfeld D; Büchner T; Koch P; Freund M; Hiddemann W; Maschmeyer G; Heyll A; Aul C; Faak T; Kuse R; Ittel T H; Gramatzki M; Diedrich H; Kolbe K; Fuhr H G; Fischer K; Schadeck-Gressel C; Weiss A; Strohscheer I; Metzner B; Fabry U; Gökbuget N; Völkers B; Messerer D; Uberla K
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Blood 1996;87(2):495-508.
1995: Behre G F; Schwartz S; Lenz K; Ludwig W D; Wandt H; Schilling E; Heinemann V; Link H; Trittin A; Boenisch O
Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.
Annals of hematology 1995;71(6):287-91.
1995: Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig W D
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Blood 1995;86(8):3097-108.
1995: Bühring H J; Sures I; Jallal B; Weiss F U; Busch F W; Ludwig W D; Handgretinger R; Waller H D; Ullrich A
The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Blood 1995;86(5):1916-23.
1995: Creutzig U; Ritter J; Ludwig W D; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
[Acute myeloid leukemia in children with Down syndrome]
Klinische Pädiatrie 1995;207(4):136-44.
1995: Rieder H; Schnittger S; Bodenstein H; Schwonzen M; Wörmann B; Berkovic D; Ludwig W D; Hoelzer D; Fonatsch C
dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia.
Genes, chromosomes & cancer 1995;13(1):54-61.
1995: Mapara M Y; Bommert K; Bargou R C; Leng C; Beck C; Ludwig W D; Gierschik P; Dörken B
G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
Blood 1995;85(7):1836-42.
1995: Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora K W; Ludwig W D; Gadner H; Riehm H
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):359-72.
1994: Schmidt C A; Przybylski G; Oettle H; Seeger K H; Ludwig W D; Siegert W
Heterogeneity of V delta 2 TCR delta gene rearrangements in acute myeloid leukemia.
Leukemia & lymphoma 1994;16(1-2):73-7.
1994: Reiter A; Schrappe M; Ludwig W D; Hiddemann W; Sauter S; Henze G; Zimmermann M; Lampert F; Havers W; Niethammer D
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Blood 1994;84(9):3122-33.
1994: Schottelius A; Brennscheidt U; Ludwig W D; Mertelsmann R H; Herrmann F; Lübbert M
Mechanisms of p53 alteration in acute leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(10):1673-81.
1994: Whitlock J A; Raimondi S C; Harbott J; Morris S W; McCurley T L; Hansen-Hagge T E; Ludwig W D; Weimann G; Bartram C R
t(5;14)(q33-34;q11), a new recurring cytogenetic abnormality in childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(9):1539-43.
1994: Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig W D; Thiel E; Freund M; Bodenstein H; Schwieder G
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(8):1318-26.
1994: Reiter A; Tiemann M; Ludwig W D; Wacker H H; Yakisan E; Schrappe M; Henzler D; Sykora K W; Brandt A; Odenwald E
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]
Klinische Pädiatrie 1994;206(4):222-33.
1994: Schmidt C A; Oettle H; Ludwig W D; Serke S; Pawlaczyk-Peter B; Wilborn F; Binder L T; Huhn D; Siegert W
Overexpression of the Raf-1 proto-oncogene in human myeloid leukemia.
Leukemia research 1994;18(6):409-13.
1994: Przybylski G; Oettle H; Ludwig W D; Siegert W; Schmidt C A
Molecular characterization of illegitimate TCR delta gene rearrangements in acute myeloid leukaemia.
British journal of haematology 1994;87(2):301-7.
1994: Ludwig W D; Raghavachar A; Thiel E
Immunophenotypic classification of acute lymphoblastic leukaemia.
Baillière's clinical haematology 1994;7(2):235-62.
1994: Griesinger F; Elfers H; Ludwig W D; Falk M; Rieder H; Harbott J; Lampert F; Heinze B; Hoelzer D; Thiel E
Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(4):542-8.
1994: Schmidt C A; Przybylski G; Vogel D; Ludwig W D; Oettle H; Neubauer A; Siegert W
Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(1):102-5.
1994: Ludwig W D; Reiter A; Löffler H; Gökbuget; Hoelzer D; Riehm H; Thiel E
Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German Multicentre Trials ALL-BFM and GMALL.
Leukemia & lymphoma 1994;13 Suppl 1():71-6.
1994: Ludwig W D; Reiter A; Schott G; Schwartz S; Thiel E
[Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance]
Wiener klinische Wochenschrift 1994;106(8):231-2, 233-7.
1993: Notter M; Ludwig W D; Bremer S; Thiel E
Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc gamma RI receptor (CD64) on autologous acute myeloid leukemic blast cells.
Blood 1993;82(10):3113-24.
1993: Sperling C; Büchner T; Sauerland C; Fonatsch C; Thiel E; Ludwig W D
CD34 expression in de novo acute myeloid leukaemia.
British journal of haematology 1993;85(3):635-7.
1993: Rieder H; Kolbus U; Koop U; Ludwig W D; Stollmann-Gibbels B; Fonatsch C
Translocation t(1;22) mimicking t(1;19) in a child with acute lymphoblastic leukemia as revealed by chromosome painting.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(10):1663-6.
1993: Hoelzer D; Thiel E; Ludwig W D; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7 Suppl 2():S130-4.
1993: de Vos S; Brach M A; Asano Y; Ludwig W D; Bettelheim P; Gruss H J; Herrmann F
Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
Cancer research 1993;53(15):3638-42.
1993: Haferlach T; Gassmann W; Löffler H; Jürgensen C; Noak J; Ludwig W D; Thiel E; Haase D; Fonatsch C; Becher R
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
Annals of hematology 1993;66(4):165-70.
1993: Zimmer B M; Berdel W E; Ludwig W D; Notter M; Reufi B; Thiel E
Fatal spleen rupture during induction chemotherapy with rh GM-CSF priming for acute monocytic leukemia. Clinical case report and in vitro studies.
Leukemia research 1993;17(3):277-83.
1993: Hiddemann W; Aul C; Maschmeyer G; Schönrock-Nabulsi R; Ludwig W D; Bartholomäus A; Bettelheim P; Becker K; Balleisen L; Lathan B
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison.
Leukemia & lymphoma 1993;10 Suppl():133-7.
1993: Sperling C; Seibt-Jung H; Gassmann W; Komischke B; Sauerland C; Hiddemann W; Löffler H; Büchner T; Thiel E; Ludwig W D
Immunophenotype of acute myeloid leukemia: correlation with morphological characteristics and therapy response.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():381-92.
1993: Ludwig W D; Harbott J; Bartram C R; Komischke B; Sperling C; Teichmann J V; Seibt-Jung H; Notter M; Odenwald E; Nehmer A
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():269-82.
1993: Teichmann J V; Ludwig W D; Thiel E
Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():223-38.
1993: Notter M; Ludwig W D; Thiel E
Preclinical studies of T-cell-mediated immune responses against autologous tumor cells in patients with acute leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():215-22.
1993: Rieder H; Ludwig W D; Gassmann W; Thiel E; Löffler H; Hoelzer D; Fonatsch C
Chromosomal abnormalities in adult acute lymphoblastic leukemia: results of the German ALL/AUL Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():133-48.
1993: Harbott J; Ritterbach J; Ludwig W D; Bartram C R; Reiter A; Lampert F
Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():123-32.
1993: Hiddemann W; Harbott J; Ludwig W D; Ritter J; Nehmer A; Reiter A; Kolkmeyer A; Laing T; Riehm H
DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():113-21.
1993: Büchner T; Hiddemann W; Wörmann B; Rottmann R; Maschmeyer G; Ludwig W D; Zühlsdorf M; Buntkirchen K; Sander A; Aswald J
The role of GM-CSF in the treatment of acute myeloid leukemia.
Leukemia & lymphoma 1993;11 Suppl 2():21-4.
1992: Schmidt C A; Oettle H; Neubauer A; Seeger K; Thiel E; Huhn D; Siegert W; Ludwig W D
Rearrangements of T-cell receptor delta, gamma and beta genes in acute myeloid leukemia coexpressing T-lymphoid features.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(12):1263-7.
1992: Büchner T; Hiddemann W; Schaefer U W; Löffler H; Maschmeyer G; Ludwig W D; Aul C; Lathan B; Heinecke A
Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():68-70.
1992: Reiter A; Schrappe M; Ludwig W D; Lampert F; Harbott J; Henze G; Niemeyer C M; Gadner H; Müller-Weihrich S; Ritter J
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
1992: Lübbert M; Oster W; Ludwig W D; Ganser A; Mertelsmann R; Herrmann F
A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.
Blood 1992;80(8):2066-73.
1992: Brach M A; Bühring H J; Gruss H J; Ashman L K; Ludwig W D; Mertelsmann R H; Herrmann F
Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein.
Blood 1992;80(5):1224-30.
1992: Pietsch T; Kyas U; Steffens U; Yakisan E; Hadam M R; Ludwig W D; Zsebo K; Welte K
Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors.
Blood 1992;80(5):1199-206.
1992: Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig W D; Harbott J; Löffler H; Schellong G
Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
The British journal of cancer. Supplement 1992;18():S63-7.
1992: Teichmann J V; Ludwig W D; Thiel E
GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cells.
International journal of hematology 1992;55(3):255-64.
1992: Teichmann J V; Ludwig W D; Thiel E
Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
Natural immunity 1992;11(3):117-32.
1992: Brach M A; Gruss H J; Asano Y; de Vos S; Ludwig W D; Mertelsmann R; Herrmann F
Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
Cancer research 1992;52(8):2197-201.
1992: Büchner T; Hiddemann W; Wörmann B; Löffler H; Maschmeyer G; Hossfeld D; Ludwig W D; Nowrousian M; Aul C; Schaefer U W
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():68-71.
1992: Hoelzer D; Thiel E; Ludwig W D; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():175-7.
1992: Teichmann J V; Ludwig W D; Thiel E
Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.
Leukemia research 1992;16(3):287-98.
1991: Büchner T; Hiddemann W; Koenigsmann M; Zühlsdorf M; Wörmann B; Boeckmann A; Freire E A; Innig G; Maschmeyer G; Ludwig W D
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.
Blood 1991;78(5):1190-7.
1991: Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig W D; Thiel E
Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Seminars in hematology 1991;28(3 Suppl 4):76-9.
1991: Hiddemann W; Aul C; Maschmeyer G; Schönrock-Nabulsi R; Ludwig W D; Bartholomäus A; Bettelheim P; Becker K; Balleisen L; Lathan B
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.
Seminars in hematology 1991;28(3 Suppl 4):35-8.
1991: Maurer J; Janssen J W; Thiel E; van Denderen J; Ludwig W D; Aydemir U; Heinze B; Fonatsch C; Harbott J; Reiter A
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.
Lancet 1991;337(8749):1055-8.
1991: Brach M A; Gauer E; Ludwig W D; Ganser A; Mertelsmann R; Herrmann F
Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.
International journal of cell cloning 1991;9(1):89-94.
1990: Ludwig W D; Teichmann J V; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
[Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies]
Klinische Pädiatrie 1990;202(4):243-52.
1990: Buechner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig W D
Recombinant human GM-CSF following chemotherapy in high-risk AML.
Bone marrow transplantation 1990;6 Suppl 1():131-4.
1990: Ludwig W D; van Dongen J J; Thiel E; Teichmann J V; Hofmann J; Riehm H
Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Onkologie 1990;13(3):166-74.
1990: Ludwig W D; Thiel E
Routine immunophenotyping of acute leukemias.
Blut 1990;60(1):48-51.
1990: Ludwig W D; Thiel E; Köller U; Bartram C R; Harbott J; Teichmann J V; Seibt-Jung H; Creutzig U; Ritter J; Riehm H
Incidence and clinical implications of acute hybrid leukemia in childhood.
Haematology and blood transfusion 1990;33():516-22.
1990: Büchner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig W D
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapse.
Haematology and blood transfusion 1990;33():724-31.
1990: Hiddemann W; Aul H C; Maschmeyer G; Urbanitz D; Lathan B; Reichle A; Köppler H; Donhuijsen-Ant R; Ludwig W D; Grüneisen T
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
Haematology and blood transfusion 1990;33():604-10.
1990: Harbott J; Ritterbach J; Janka-Schaub G; Ludwig W D; Reiter A; Riehm H; Lampert F
Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trials.
Haematology and blood transfusion 1990;33():451-8.
1990: Ludwig W D; Thiel E; Bartram C R; Kranz B R; Raghavachar A; Löffler H; Ganser A; Büchner T; Hiddemann W; Heil G
Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage.
Haematology and blood transfusion 1990;33():419-27.
1990: Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig W D
Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
Haematology and blood transfusion 1990;33():261-6.
1990: Teichmann J V; Ludwig W D; Seibt-Jung H; Thiel E
Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines.
Haematology and blood transfusion 1990;33():103-9.
1989: Köller U; Haas O A; Ludwig W D; Bartram C R; Harbott J; Panzer-Grümayer R; Hansen-Hagge T; Ritter J; Creutzig U; Knapp W
Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(10):708-14.
1989: Teichmann J V; Ludwig W D; Seibt-Jung H; Thiel E
Induction of lymphokine-activated killer cell against human leukemia cells in vitro.
Blut 1989;59(1):21-4.
1989: Ludwig W D; Bartram C R; Harbott J; Köller U; Haas O A; Hansen-Hagge T; Heil G; Seibt-Jung H; Teichmann J V; Ritter J
Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(6):431-9.
1989: Teichmann J V; Sieber G; Ludwig W D; Ruehl H
Immunosuppressive effects of recombinant interferon-alpha during long-term treatment of cancer patients.
Cancer 1989;63(10):1990-3.
1989: Thiel E; Kranz B R; Raghavachar A; Bartram C R; Löffler H; Messerer D; Ganser A; Ludwig W D; Büchner T; Hoelzer D
Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia.
Blood 1989;73(5):1247-58.
1989: Hiddemann W; Aul C; Maschmeyer G; Lathan B; Köppler H; Hoffmann R; Grüneisen T; Donhuijsen-Ant R; Ludwig W D; Balleisen L
Age related randomized comparison of sequentially applied high-dose versus intermediate dose cytosine arabinoside in combination with mitoxantrone (S-HAM) in the treatment of relapsed and refractory acute myeloid leukemia: study design and preliminary results.
Onkologie 1989;12(1):4-6.
1989: Ludwig W D; Seibt-Jung H; Teichmann J V; Komischke B; Gatzke A; Gassner G; Odenwald E; Hofmann J; Riehm H
Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL Study 83.
Haematology and blood transfusion 1989;32():51-7.
1989: Teichmann J V; Ludwig W D; Seibt-Jung H; Sieber G; Thiel E
Induction of lymphokine-activated killer (LAK) cells against human leukemia cells.
Haematology and blood transfusion 1989;32():449-52.
1989: Baumgarten E; Wegner R D; Fengler R; Ludwig W D; Schulte-Overberg U; Domeyer C; Schüürmann J; Henze G
Calla-positive acute leukaemia with t(5q;14q) translocation and hypereosinophilia--a unique entity?
Acta haematologica 1989;82(2):85-90.
1988: Ludwig W D; Bartram C R; Ritter J; Raghavachar A; Hiddemann W; Heil G; Harbott J; Seibt-Jung H; Teichmann J V; Riehm H
Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis.
Blood 1988;71(6):1518-28.
1988: Lampert F; Harbott J; Ritterbach J; Ludwig W D; Fonatsch C; Schwamborn D; Stier B; Gnekow A; Gerein V; Stollmann B
T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients.
Blut 1988;56(3):117-23.
1988: Teichmann J V; Sieber G; Ludwig W D; Ruehl H
Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
Journal of interferon research 1988;8(1):15-24.
1988: Keyserlingk H; Ludwig W D; Seibt H; Rühl H; Höffken G
Atypical presentation of Hodgkin's disease in a patient at risk for the acquired immunodeficiency syndrome.
Cancer detection and prevention 1988;12(1-6):243-8.
1987: Lampert F; Harbott J; Ludwig W D; Bartram C R; Ritter J; Gerein V; Neidhardt M; Mertens R; Graf N; Riehm H
Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases.
Blut 1987;54(6):325-35.
1987: Hiddemann W; Kreutzmann H; Straif K; Ludwig W D; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
Seminars in oncology 1987;14(2 Suppl 1):73-7.
1987: Teichmann J; Sieber G; Ludwig W D; Rühl H
[Thrombotic thrombocytopenic purpura within the scope of disseminated tumor disease]
Der Internist 1987;28(6):388-92.
1987: Hiddemann W; Kreutzmann H; Straif K; Ludwig W D; Mertelsmann R; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.
Blood 1987;69(3):744-9.
1987: Ludwig W D; Hiddemann W; Herrmann F; Seibt H; Komischke B; Rühl H
Abnormal marker expression in acute leukemia (AL) characterized by monoclonal antibodies and flow cytometry.
Haematology and blood transfusion 1987;30():265-70.
1987: Urbanitz D; Büchner T; Pielken H; Koch P; Ludwig W D; Maschmeier G; Heinecke A; van de Loo J
Neuraminidase-treated allogeneic blasts for maintenance in acute myelogenous leukemia: results of a prospective randomized trial.
Haematology and blood transfusion 1987;30():64-8.
1987: Hiddemann W; Kreutzmann H; Straif K; Ludwig W D; Fuhr H J; Donhuijsen-Ant R; Lengfelder E; Büchner T
Phase I/II trial of high-dose cytosine arabinoside and mitoxantrone in adult refractory acute myeloid leukemia.
Haematology and blood transfusion 1987;30():336-8.
1986: Hiddemann W; Kreutzmann H; Straif K; Ludwig W D; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
High-dose cytosine-arabinoside and mitoxantrone in refractory acute myeloid leukemia: a clinical phase I/II-study.
Onkologie 1986;9(3):144-6.
1986: Teichmann J V; Sieber G; Ludwig W D; Karow J; Ruehl H
Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia. Case report and review of the literature.
Leukemia research 1986;10(4):361-8.
1985: Büchner T; Urbanitz D; Hiddemann W; Rühl H; Ludwig W D; Fischer J; Aul H C; Vaupel H A; Kuse R; Zeile G
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(12):1583-9.
1985: Sieber G; Teichmann H; Ludwig W D; Rühl H
B-cell function in AIDS.
Blut 1985;51(3):143-4.
1985: Hiddemann W; Kreutzmann H; Ludwig W D; Aul H C; Donhuijsen-Ant R; Lengfelder E; Büchner T
Mitozantrone and high-dose cytarabine in refractory adult acute myeloid leukaemia.
Lancet 1985;2(8453):508-9.
1985: Sieber G; Ludwig W D; Teichmann H; Herrmann F; Rühl H
Coincident change of cellular function and phenotype in the course of a suppressor T cell acute lymphocytic leukaemia.
Clinical and experimental immunology 1985;60(3):483-8.
1985: Herrmann F; Kolecki P; Sieber G; Ludwig W D; Komischke B; Rühl H
Chronic lymphocytic leukemia B-lymphocytes forming SRBC-rosettes not due to an anti-SRBC activity of monoclonal surface immunoglobulin.
American journal of clinical pathology 1985;83(2):249-53.
1985: Sieber G; Ludwig W D; Rühl H
[Characterization of the leukemic cell population in a patient with T-ALL at disease beginning and in recurrence: parallel changes in phenotypic and functional behavior]
Immunität und Infektion 1985;13(1):35-6.
1984: Herrmann F; Komischke B; Kolecki P; Ludwig W D; Sieber G; Teichmann H; Rühl H
Ph1 positive blast crisis of chronic myeloid leukaemia exhibiting features characteristic of early T blasts.
Scandinavian journal of haematology 1984;32(4):411-6.
1984: Herrmann F; Komischke B; Langermann H J; Ludwig W D; Sieber G; Rühl H
p69,71 antigen complex detected by monoclonal antibody Leu 1 in the identification of particular stages of malignant B-cell differentiation.
Scandinavian journal of haematology 1984;32(2):215-22.
1983: Herrmann F; Komischke B; Odenwald E; Ludwig W D
Use of monoclonal antibodies as a diagnostic tool in human leukemia. I. Acute myeloid leukemia and acute phase of chronic myeloid leukemia.
Blut 1983;47(3):157-63.
1983: Herrmann F; Sieber G; Komischke B; Schreckenberg A; Ludwig W D; Rühl H
Expanded T gamma cell populations with the morphology of large granular lymphocytes -- I. Immunological, clinical and morphological characterization.
Leukemia research 1983;7(5):667-80.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Wolf-Dieter Ludwig

Research Profile (preview)

Disorders

Procedures

Living Beings

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Wolf-Dieter Ludwig (preview)

All Publications